Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,926,284
+$465,690 QoQ
Shares Held
1,606
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,529
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. LLY ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,926,284 | 1,606 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,460,594 | 1,588 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,690,471 | 1,573 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,235,297 | 1,619 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,275,311 | 1,636 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,333,018 | 1,614 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,317,804 | 1,707 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,600,893 | 1,807 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,749,194 | 1,932 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,186,845 | 2,811 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,445,932 | 4,196 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,253,797 | 4,196 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,272,677 | 4,846 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,818,752 | 5,296 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,038,094 | 5,571 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,874,136 | 5,796 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,989,475 | 6,136 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,201,608 | 4,196 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,262,601 | 4,571 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,056,129 | 4,571 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,028,938 | 4,483 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $856,569 | 4,585 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $780,885 | 4,625 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $684,592 | 4,625 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $771,646 | 4,700 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $658,920 | 4,750 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||